Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$402,978
-$66,940 QoQ
Shares Held
16,735
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,902
of 2,821 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Defender Capital, LLC. holds $682,345 across 2 Drug Manufacturers - General names. PFE ranks #1 (59.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
16,735 | $402,978 | |
| 2 | JNJ |
Johnson & Johnson
|
1,100 | $279,367 |
All Filings in PFE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $402,978 | 16,735 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $469,918 | 16,735 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $416,701 | 16,735 | Shares | Sole | 2026-01-12 | |
| 2025-06-30 | $405,656 | 16,735 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $414,942 | 16,375 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $449,285 | 16,935 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $519,038 | 17,935 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $501,821 | 17,935 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $498,251 | 17,955 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $516,348 | 17,935 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $594,903 | 17,935 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $657,855 | 17,935 | Shares | Sole | 2023-07-18 | |
| 2021-12-31 | $763,811 | 12,935 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $440,336 | 10,238 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $399,432 | 10,200 | Shares | Sole | 2021-07-29 | |
| No filing history on record for this holder in this stock. | ||||||